Studies have shown that active fund managers routinely underperform the S&P500 index*​

Aura Biosciences, Inc. (NASDAQ: AURA)

AURA Stock Predictions and Ratings

WSX Rating:
NOT AVAILABLE
WSX Forecast (1yr):
NOT AVAILABLE
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
210.10%

AURA Stock Analysis

AURA PE Ratio:

AURA PEG Ratio: Not Available

AURA Forward EPS Growth (12 month): 0.00%

AURA PS Ratio:

AURA PSG Ratio: Not Available

AURA Forward Revenue Growth (12 month): 0.00%

AURA Articles

No data was found